Pfizer has upped the ante in the increasingly competitive market for pneumococcal vaccines with mid-stage clinical data for a new shot covering 25 strains – five more than its current Prevnar 20 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results